Integrated Filing — IndAS

General information about company
Scrip Code	532296
NSE Symbol	GLENMARK
MSEI Symbol	NOTLISTED
ISIN	INE935A01035
Name of company	Glenmark Pharmaceuticals Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	23-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	12-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Pharmaceuticals
Start date and time of board meeting	23-May-2025   14:00:00
End date and time of board meeting	23-May-2025   16:54:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	32562060000	133217400000
	Other income	116850000	1137220000
	Total income	32678910000	134354620000
2	Expenses
(a)	Cost of materials consumed	7947760000	30012720000
(b)	Purchases of stock-in-trade	3447440000	15660030000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-505720000	-2139330000
(d)	Employee benefit expense	7365700000	30220610000
(e)	Finance costs	667120000	2070650000
(f)	Depreciation, depletion and amortisation expense	1252050000	4860100000
(f)	Other Expenses
1	Other Expenses	8696630000	35949560000
	Total other expenses	8696630000	35949560000
	Total expenses	28870980000	116634340000
3	Total profit before exceptional items and tax	3807930000	17720280000
4	Exceptional items	-3728190000	-3728190000
5	Total profit before tax	79740000	13992090000
6	Tax expense
7	Current tax	-35040000	3823410000
8	Deferred tax	70940000	-302740000
9	Total tax expenses	35900000	3520670000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	43840000	10471420000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	43840000	10471420000
17	Other comprehensive income net of taxes	2575790000	641980000
18	Total Comprehensive Income for the period	2619630000	11113400000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	46500000	10470970000
	Total profit or loss, attributable to non-controlling interests	-2660000	-2660000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	2622460000	11113320000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	-2830000	80000
21	Details of equity share capital
	Paid-up equity share capital	282190000	282190000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		88212210000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.16	37.11
	Diluted earnings (loss) per share from continuing operations	0.16	37.1
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	0.16	37.11
	Diluted earnings (loss) per share from continuing and discontinued operations	0.16	37.1
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	33193660000
	Capital work-in-progress	5419870000
	Investment property	0
	Goodwill	702660000
	Other intangible assets	10971930000
	Intangible assets under development	2928400000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	563550000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	729420000
	Total non-current financial assets	1292970000
	Deferred tax assets (net)	11241090000
	Other non-current assets	1790310000
	Total non-current assets	67540890000
2	Current assets
	Inventories	30285300000
	Current financial asset
	Current investments	0
	Trade receivables, current	33419470000
	Cash and cash equivalents	16757070000
	Bank balance other than cash and cash equivalents	295210000
	Loans, current	0
	Other current financial assets	624460000
	Total current financial assets	51096210000
	Current tax assets (net)	11573140000
	Other current assets
	Total current assets	92954650000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	160495540000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	282190000
	Other equity	88212220000
	Total equity attributable to owners of parent	88494410000
	Non controlling interest	-3710000
	Total equity	88490700000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	5127000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	6621720000
	Total non-current financial liabilities	11748720000
	Provisions, non-current	0
	Deferred tax liabilities (net)	585880000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	12334600000
	Current liabilities
	Current financial liabilities
	Borrowings, current	16814950000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	214410000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	25580890000
	Total Trade payable	25795300000
	Other current financial liabilities	8825440000
	Total current financial liabilities	51435690000
	Other current liabilities	1989980000
	Provisions, current	5960830000
	Current tax liabilities (Net)	283740000
	Deferred government grants, Current
	Total current liabilities	59670240000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	72004840000
	Total equity and liabilites	160495540000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit or loss	-61880000	-119760000
	Total Amount of items that will not be reclassified to profit and loss	-61880000	-119760000
2	Income tax relating to items that will not be reclassified to profit or loss	-19540000	-38360000
3	Amount of items that will be reclassified to profit and loss
1	Items that will be reclassified to profit or loss	2609560000	867400000
	Total Amount of items that will be reclassified to profit and loss	2609560000	867400000
4	Income tax relating to items that will be reclassified to profit or loss	-8570000	144020000
5	Total Other comprehensive income	2575790000	641980000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			13992090000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			2070650000
	Adjustments for decrease (increase) in inventories			-4508070000
	Adjustments for decrease (increase) in trade receivables, current			-14203290000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			1561980000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-8137540000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			4860100000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			30660000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-690580000
	Adjustments for dividend income			0
	Adjustments for interest income			439340000
	Adjustments for share-based payments			-91730000
	Adjustments for fair value losses (gains)			270000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-24470000
	Other adjustments to reconcile profit (loss)			373770000
	Other adjustments for non-cash items			3730810000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-15466780000
	Net cash flows from (used in) operations			-1474690000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			6801260000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			-8275950000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			7357270000
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			7495690000
	Proceeds from sales of investment property			24200000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			60000
	Interest received			421180000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-286080000
	Net cash flows from (used in) investing activities	20940000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			300680000
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			13411890000
	Repayments of borrowings			1406770000
	Payments of lease liabilities			1221780000
	Dividends paid			704420000
	Interest paid			1907790000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			7870450000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-384560000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			558930000
	Net increase (decrease) in cash and cash equivalents			174370000
	Cash and cash equivalents cash flow statement at beginning of period			16582700000
	Cash and cash equivalents cash flow statement at end of period			16757070000